The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise
- PMID: 38897893
- DOI: 10.1016/j.vaccine.2024.05.075
The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise
Abstract
Promoting vaccine acceptance and demand is an essential, yet often underrecognized component of ensuring that everyone has access to the full benefits of immunization. Convened by the Sabin Vaccine Institute, the Vaccination Acceptance Research Network (VARN) is a global network of multidisciplinary stakeholders driving strengthened vaccination acceptance, demand, and delivery. VARN works to advance and apply social and behavioral science insights, research, and expertise to the challenges and opportunities facing vaccination decision-makers. The second annual VARN conference, When Communities Lead, Global Immunization Succeeds, was held June 13-15, 2023, in Bangkok, Thailand. VARN2023 provided a space for the exploration and dissemination of a growing body of evidence, knowledge, and practice for driving action across the vaccination acceptance, demand, and delivery ecosystem. VARN2023 was co-convened by Sabin and UNICEF and co-sponsored by Gavi, the Vaccine Alliance. VARN2023 brought together 231 global, regional, national, sub-national, and community-level representatives from 47 countries. The conference provided a forum to share learnings and solutions from work conducted across 40+ countries. This article is a synthesis of evidence-based insights from the VARN2023 Conference within four key recommendations: (1) Make vaccine equity and inclusion central to programming to improve vaccine confidence, demand, and delivery; (2) Prioritize communities in immunization service delivery through people-centered approaches and tools that amplify community needs to policymakers, build trust, and combat misinformation; (3) Encourage innovative community-centric solutions for improved routine immunization coverage; and (4) Strengthen vaccination across the life course through building vaccine demand, service integration, and improving the immunization service experience. Insights from VARN can be applied to positively impact vaccination acceptance, demand, and uptake around the world.
Keywords: COVID-19; Immunization; Life-course immunization; Routine immunization; Vaccination; Vaccination demand; Vaccine acceptance; Vaccine confidence; Vaccine hesitancy; Vaccine uptake.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Rupali Limaye reports a relationship with Sabin Vaccine Institute that includes: funding grants. Eve Dube reports a relationship with Sabin Vaccine Institute that includes: travel reimbursement. Holly Seale reports a relationship with Sabin Vaccine Institute that includes: travel reimbursement. Rubina Qasim reports a relationship with Sabin Vaccine Institute that includes: travel reimbursement. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper..
Similar articles
-
Building a way forward: Enabling community voices to forge the path toward successful immunization for all.Vaccine. 2024 Nov 14;42 Suppl 5(Suppl 5):126017. doi: 10.1016/j.vaccine.2024.05.065. Epub 2024 Jun 14. Vaccine. 2024. PMID: 38879408 Free PMC article.
-
Shaping global vaccine acceptance with localized knowledge: a report from the inaugural VARN2022 conference.BMC Proc. 2023 Oct 5;17(Suppl 7):26. doi: 10.1186/s12919-023-00280-z. BMC Proc. 2023. PMID: 37798780 Free PMC article.
-
Costs of vaccine programs across 94 low- and middle-income countries.Vaccine. 2015 May 7;33 Suppl 1:A99-108. doi: 10.1016/j.vaccine.2014.12.037. Vaccine. 2015. PMID: 25919184
-
New immunization strategies: adapting to global challenges.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):25-31. doi: 10.1007/s00103-019-03066-x. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31802153 Free PMC article. Review.
-
A rapid review of evidence on the determinants of and strategies for COVID-19 vaccine acceptance in low- and middle-income countries.J Glob Health. 2021 Nov 20;11:05027. doi: 10.7189/jogh.11.05027. eCollection 2021. J Glob Health. 2021. PMID: 34912550 Free PMC article. Review.
Cited by
-
Lessons for medical countermeasure development from unforeseen outbreaks.Emerg Microbes Infect. 2025 Dec;14(1):2471035. doi: 10.1080/22221751.2025.2471035. Epub 2025 Mar 10. Emerg Microbes Infect. 2025. PMID: 39976365 Free PMC article. Review.
-
Trust, Information and Vaccine Aonfidence in Crisis Settings: A Scoping Review.Public Health Chall. 2025 Jun 26;4(3):e70073. doi: 10.1002/puh2.70073. eCollection 2025 Sep. Public Health Chall. 2025. PMID: 40584000 Free PMC article. Review.
-
Predicting clinical outcomes at hospital admission of patients with COVID-19 pneumonia using artificial intelligence: a secondary analysis of a randomized clinical trial.Front Med (Lausanne). 2025 May 2;12:1561980. doi: 10.3389/fmed.2025.1561980. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40385586 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical